Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
Tax Provision
Mayne Pharma Group Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mayne Pharma Group Ltd
ASX:MYX
|
Tax Provision
-AU$47.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Tax Provision
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Tax Provision
-AU$48.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Tax Provision
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Probiotec Ltd
ASX:PBP
|
Tax Provision
-AU$4.3m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-56%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Tax Provision
-AU$103.2k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Mayne Pharma Group Ltd's Tax Provision?
Tax Provision
-47.7m
AUD
Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Tax Provision amounts to -47.7m AUD.
What is Mayne Pharma Group Ltd's Tax Provision growth rate?
Tax Provision CAGR 1Y
36%
Over the last year, the Tax Provision growth was 36%.